預防醫學研究所;Institute of Preventive MedicineLIN, RUE-SHENRUE-SHENLINCHEN, TONY, HSIU-HISTONY, HSIU-HISCHEN陳秀熙2008-08-272018-06-292008-08-272018-06-292003http://ntur.lib.ntu.edu.tw//handle/246246/81597Cost-benefit analysis was conducted to determine whether it is worthwhile to initiate a routine varicella vaccination program in Taiwan from different perspectives. Using the human capital approach, the discounted net cost for vaccination program was New Taiwan Dollars (NTD) 281 million from health care payer's perspective. Taking indirect costs into account, the net saving due to vaccination program was NTD 425 million from the societal perspective. In terms of benefit-cost ratio, a mass varicella vaccination program could only save NTD 0.34 in discounted costs for each dollar incurred in a vaccination program from health care payer's perspective whereas save NTD 2.06 from the societal viewpoint. Results based on the willingness-to-pay (WTP) method showed the Net Present Value (NPV) of the vaccination program was estimated as -NTD 272 million. We conclude that a routine varicella vaccination program is worthwhile from the societal perspective but neither from health care payer's nor from consumer decision based on the perspective of WTP. (C) 2003 Elsevier Science Ltd. All rights reserved.en-USVARICELLA VACCINATIONCHILDRENLEUKEMIAZOSTEREPIDEMIOLOGYIMMUNIZATION[SDGs]SDG3journal article